| 本文言語 | English |
|---|---|
| ページ（範囲） | 1088-1089 |
| ページ数 | 2 |
| ジャーナル | Journal of Allergy and Clinical Immunology |
| 巻 | 135 |
| 号 | 4 |
| DOI | |
| 出版ステータス | Published - 2015 4月 1 |
| 外部発表 | はい |
ASJC Scopus subject areas
- 免疫アレルギー学
- 免疫学
引用スタイル
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Journal of Allergy and Clinical Immunology, Vol. 135, No. 4, 01.04.2015, p. 1088-1089.
研究成果: Letter › 査読
}
TY - JOUR
T1 - Reply
AU - Horimukai, Kenta
AU - Morita, Kumiko
AU - Inoue, Eisuke
AU - Saito, Hirohisa
AU - Ohya, Yukihiro
N1 - Funding Information: Disclosure of potential conflict of interest: K. Horimukai is employed by the National Center for Child Health and Development (NCCHD) and the Jikei University Katsushika Medical Center; has received research support from the Ministry of Health, Labour and Welfare (the grant no. of MHLW is henceforth H22-Men'eki-Ippan-002 and H25-Nanchito-Ippan-001 , unless otherwise specified); and has received payment for lectures from Maruho Co Ltd and GlaxoSmithKline KK. K. Morita is employed by the NCCHD; has received research support from Shiseido Co, Ltd , and the Ministry of Health, Labour and Welfare . E. Inoue has consultant arrangements with Tokyo Women's Medical University and Stagen Co, Ltd; is employed by the NCCHD; has received research support from the Ministry of Health, Labour and Welfare and the Ministry of Education, Culture, Sports, Science, and Technology ; and has received payment for lectures from Takeda Pharmaceutical Co, Ltd, Chugai Pharmaceutical Co Ltd, and Japan Clinical Cancer Research Organization. H. Saito is employed by the NCCHD; has received research support from the Ministry of Health, Labour and Welfare and Japan Society for the Promotion of Science ( 21390303 & 23390262 ); has received payment for lectures from Teijin Pharma Ltd, Shiseido Co Ltd, Merck Sharp and Dohme KK, Taiho Pharmaceutical Co Ltd, Nippon Boehringer-Ingelheim Co Ltd, Ono Pharmaceutical Co Ltd, GlaxoSmithKline KK, Pfizer Japan, Inc, Novartis Pharma KK, Kyowa Hakko Kirin Co Ltd, Kyorin Pharmaceutical Co Ltd, and Daiichi Sankyo Co Ltd; has received payment for manuscript preparation from Taiho Pharmaceutical Co Ltd; has received payment for the development of educational presentations from Shimane University and Toho University; and has received travel support from Shimane University Japanese Society of Allergology , Japanese Society of Pediatric Allergy & Clinical Immunology , and Pfizer Japan, Inc . Y. Ohya is employed by the NCCHD; has received research support from the Ministry of Health, Labour and Welfare , the NCCHD , the Environmental Restoration & Conservation Agency , Shiseido Co Ltd , Maruho Co Ltd , and the National Institute for Environmental Studies ; has received payment for lectures from Merck Sharp and Dohme, GlaxoSmithKline KK, Malho Co Ltd, Teijin Pharma Ltd, Shiseido Co Ltd, Abbott Japan Co Ltd, Sanofi KK, Simens AG, Kyowa Hakko Kirin Co Ltd, and Nikkei Radio Broadcasting Co; has received payment for manuscript preparation from the University of Tokyo Press, Tokyo Igakusha, and the Asahi Shinbun; has received payment for the development of educational presentations from the Japan Allergy Foundation, the Japan Pharmacists Education Center, NHK Educational Co, and the Korean Pediatric Society; and has received travel support from the Japanese Society of Child Health , the Japanese Society of Pediatric Dermatology , Tokyo metropolitan government , the National Institute for Environmental Studies , the Ministry of Environment , and the Cabinet Office .
PY - 2015/4/1
Y1 - 2015/4/1
UR - http://www.scopus.com/inward/record.url?scp=84926256731&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84926256731&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2014.12.1934
DO - 10.1016/j.jaci.2014.12.1934
M3 - Letter
C2 - 25665730
AN - SCOPUS:84926256731
SN - 0091-6749
VL - 135
SP - 1088
EP - 1089
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 4
ER -